| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―May―10 |
Patent scenario of COVID-19 vaccines: A promising analysis and review of innovation and development |
Lavanya Madhusoodanan, Patrika Soni, Rahul Sharma, Amit Dubey |
| 2 |
[GO] |
2023―May―10 |
Copyright Law Protection of films in Nigeria (Nollywood) and South Africa (Sollywood): Pre and post-Covid-19 pandemic |
Jade Kouletakis, Ayoyemi Lawal-Arowolo, Nkem Itanyi |
| 3 |
[GO] |
2023―Apr―11 |
Intellectual property rights in outer space: How can pharmaceutical companies protect COVID-19 vaccine and immunotherapy developments aboard the ISS US national laboratory? |
Adnan Jashari, Stefani Stojchevska |
| 4 |
[GO] |
2023―Apr―06 |
Why patent waiver for Covid-19 vaccines and pharmaceuticals? |
Mrityunjay Kumar, Nalin Bharti |
| 5 |
[GO] |
2022―Nov―04 |
The social function of intellectual property and government intervention in mitigating the pandemic: A perspective from Indonesia |
Ranti F. Mayana, Tisni Santika |
| 6 |
[GO] |
2022―May―09 |
Patent law and 3D printing applications in response to COVID-19: Exceptions to inventor rights |
Muhammad Z. Abbas |
| 7 |
[GO] |
2022―Apr―01 |
The COVID-19 pandemic and long-term incentives for developing vaccines: Patent law under stress |
Mitja Kovac, Lana Rakovec |
| 8 |
[GO] |
2022―Mar―07 |
Role of traditional knowledge in the COVID-19 battle |
Kunle Ola |
| 9 |
[GO] |
2022―Jan―31 |
Patent waiver on COVID-19 vaccine: Indonesian law perspective |
Ahmad M. Ramli, Tasya S. Ramli, Gabriela M. Hutauruk |
| 10 |
[GO] |
2021―Sep―09 |
TRIPS waiver of COVID-19 vaccines: Impact on pharmaceutical industry and what it means to developing countries |
Talat Chaudhary, Arshi Chaudhary |
| 11 |
[GO] |
2021―Aug―02 |
The debate around the access to vaccine and licensing amidst second wave of COVID-19 in India |
Sparsh Sharma |
| 12 |
[GO] |
2021―Mar―18 |
Does TRIPS (agreement on trade-related aspects of intellectual property rights) prevent COVID-19 vaccines as a global public good? |
Hans Morten Haugen |
